Spruce Biosciences to Participate in May Investor Conferences
May 03 2022 - 4:05PM
Business Wire
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage
biopharmaceutical company focused on developing and commercializing
novel therapies for rare endocrine disorders with significant unmet
medical need, today announced that company management will
participate in two upcoming investor conferences taking place in
May.
- RBC Capital Markets Global Healthcare Conference Date:
May 17-18, 2022 Format: Fireside chat (May 17 at 10:00 a.m.
ET) and 1x1 meetings
- H.C. Wainwright Global Investment Conference Date: May
23-26, 2022 Format: Company presentation (May 25 at 4:00
p.m. ET) and 1x1 meetings
Interested parties can access the webcast for each conference
presentation from the Events section of the company’s investor
relations website at https://investors.sprucebiosciences.com. A
replay of the webcasts will be available after the conclusion of
the live presentations for approximately 30 days.
About Spruce Biosciences
Spruce Biosciences is a late-stage biopharmaceutical company
focused on developing and commercializing novel therapies for rare
endocrine disorders with significant unmet medical need. Spruce is
initially developing its wholly-owned product candidate,
tildacerfont, as the potential first non-steroidal therapy for
patients suffering from classic congenital adrenal hyperplasia
(CAH). Classic CAH is a serious and life-threatening disease with
no known novel therapies approved in approximately 50 years. Spruce
is also developing tildacerfont for women suffering from polycystic
ovary syndrome (PCOS) with primary adrenal androgen excess. To
learn more, visit www.sprucebiosciences.com and follow us on
Twitter @Spruce_Bio, LinkedIn, Facebook and YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220503005051/en/
Media Contact Will Zasadny Canale Communications (619)
961-8848 will.zasadny@canalecomm.com
media@sprucebiosciences.com
Investors Xuan Yang Solebury Trout (415) 971-9412
xyang@soleburytrout.com investors@sprucebiosciences.com
Spruce Biosciences (NASDAQ:SPRB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spruce Biosciences (NASDAQ:SPRB)
Historical Stock Chart
From Apr 2023 to Apr 2024